Li, A.A.; Cholankeril, G.; Cheng, X.S.; Tan, J.C.; Kim, D.; Toll, A.E.; Nair, S.; Ahmed, A.
Underutilization of Hepatitis C Virus Seropositive Donor Kidneys in the United States in the Current Opioid Epidemic and Direct-Acting Antiviral Era. Diseases 2018, 6, 62.
https://doi.org/10.3390/diseases6030062
AMA Style
Li AA, Cholankeril G, Cheng XS, Tan JC, Kim D, Toll AE, Nair S, Ahmed A.
Underutilization of Hepatitis C Virus Seropositive Donor Kidneys in the United States in the Current Opioid Epidemic and Direct-Acting Antiviral Era. Diseases. 2018; 6(3):62.
https://doi.org/10.3390/diseases6030062
Chicago/Turabian Style
Li, Andrew A., George Cholankeril, Xingxing S. Cheng, Jane C. Tan, Donghee Kim, Alice E. Toll, Satheesh Nair, and Aijaz Ahmed.
2018. "Underutilization of Hepatitis C Virus Seropositive Donor Kidneys in the United States in the Current Opioid Epidemic and Direct-Acting Antiviral Era" Diseases 6, no. 3: 62.
https://doi.org/10.3390/diseases6030062
APA Style
Li, A. A., Cholankeril, G., Cheng, X. S., Tan, J. C., Kim, D., Toll, A. E., Nair, S., & Ahmed, A.
(2018). Underutilization of Hepatitis C Virus Seropositive Donor Kidneys in the United States in the Current Opioid Epidemic and Direct-Acting Antiviral Era. Diseases, 6(3), 62.
https://doi.org/10.3390/diseases6030062